From: Contribution of diminished kidney transplant GFR to increased circulating chemokine ligand 27 level
Variables | Group 1 eGFR. ≥ 60 (77.27 ± 17.07) | Group 2 eGFR 30–59.9 (46.69 ± 8.92) | Group 3 eGFR≤ 29.9 (21.43 ± 5.81) | ANOVA / K / Chi2 | P |
---|---|---|---|---|---|
Age (Years) | 47.04 + 15.14 | 52.10 + 12.45 | 50.15 + 15.04 | 1.28 | 0.28 |
Gender: | |||||
 M: No (%) | 17 (54.8%) | 25 (50%) | 16 (80%) | 5.4a | 0.08 |
 F: No (%) | 14 (45.2%) | 25 (50%) | 4 (20%) | ||
BMI | 27.23 + 4.27 | 29.01 + 5.43 | 27.32 + 5.76 | 1.5 | 0.23 |
Tx duration (Years) | 7.48 + 5.75 | 6.31 + 4.20 | 8.95 + 3.88 | 2.4 | 0.09 |
SBP (mmHg) | 128.3 + 12.7 | 127.1 + 14.0 | 134.7 + 18.3 | 2.0 | 0.14 |
DBP (mmHg) | 77.65 + 8.55 | 79.1 + 11.4 | 79.3 + 9.9 | 0.23 | 0.8 |
Dialysis: | |||||
 HD | 15 (57.7%) | 22 (53.7%) | 13 (72.2%) | 1.8a | 0.41 |
 PD | 11 (42.3%) | 19 (48.3%) | 5 (27.8%) | ||
Donor: | |||||
 Living | 11 (39.3%) | 20 (42.6%) | 6 (30%) | 0.93a | 0.63 |
 Deceased | 17 (60.7%) | 27 (57.4%) | 14 (70%) | ||
Diabetes: | |||||
 Yes | 9 (29%) | 17 (34%) | 6 (30%) | 0.25a | 0.88 |
 No | 22 (71%) | 33 (66%) | 14 (70%) | ||
Smoking: | |||||
 Yes | 9 (29%) | 8 (16.3%) | 4 (20%) | 1.90a | 0.39 |
 No | 22 (71%) | 41 (83.7%) | 16 (80%) | ||
HB (g/L) | 126.6 + 12.6 | 125.3 + 16.9 | 111.4 + 15.9 | 6.9 | 0.002 |
Ca (mmol/L) | 2.36 + 0.13 | 2.35 + 0.17 | 2.34 + 0.27 | 0.04 | 0.95 |
PO4(mmol/L) | 0.89 + 0.23 | 1.0 + 0.25 | 1.2 + 0.31 | 10.7 | 0.000 |
iPTH (pg/ml) | 14.76 + 18.72 | 9.02 + 4.99 | 26.82 + 28.66 | 10.03b | 0.007 |
Cholesterol (mmol/L) | 4.47 + 0.93 | 4.20 + 1.30 | 4.98 + 1.16 | 1.8 | 0.17 |
TG (mmol/L) | 1.75 + 0.72 | 2.03 + 1.14 | 2.19 + 1.14 | 1.2 | 0.3 |
LDL (mmol/L) | 2.37 + 0.77 | 2.68 + 0.99 | 2.72 + 0.99 | 1.3 | 0.28 |
HDL (mmol/L) | 1.31 + 0.44 | 1.41 + 0.44 | 1.24 + 0.39 | 1.3 | 0.29 |
Albumin (g/L) | 37.37 + 4.34 | 38.59 + 3.65 | 35.90 + 5.31 | 2.9 | 0.06 |
ACR (mg/mmol) | 26.14 + 33.81 | 78.9 + 123.2 | 186.5 + 163.6 | 17.8b | 0.000 |
HS CRP (mg/L) | 5.1 + 7.8 | 6.8 + 12.0 | 6.7 + 6.2 | 4.86b | 0.088 |